NCT07592325

Brief Summary

Transtibial amputation significantly impacts patient autonomy and quality of life, primarily due to the limitations of conventional rigid sockets, which restrict comfort and joint range of motion. The Access Socket (AS) is an innovative prosthetic socket combining a rigid carbon-fiber structure in key load-bearing areas with flexible urethane-resin (ProtheFLEX®) zones in regions typically rigid in conventional sockets. This hybrid design aims to improve comfort and pressure distribution while preserving the mechanical properties required for ambulation. The AS has already demonstrated benefits in transfemoral amputees and is now reimbursed in France for that population. A preliminary uncontrolled study in 12 transtibial amputees suggested significant improvements in perceived function, comfort, satisfaction, and mobility. This multicenter, randomized, open-label, two-arm crossover study aims to compare the (AS) with the standard rigid socket (RS) in 25 adults with transtibial amputation. Participants will wear each socket for approximately 4 weeks (after a 1-2 week adaptation period) in a randomized order. The primary outcome is the Patient Specific Functional Scale (PSFS). Secondary outcomes include comfort (SCS), satisfaction (OPUS), psychosocial adjustment (TAPES-R), mobility (PLUS-M), prosthesis utility (PEQ-U), and the proportion of patients electing to keep the AS at study completion.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
15mo left

Started Apr 2026

Geographic Reach
1 country

5 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress18%
Apr 2026Oct 2027

Study Start

First participant enrolled

April 27, 2026

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 18, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 27, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2027

Last Updated

May 18, 2026

Status Verified

May 1, 2026

Enrollment Period

1 year

First QC Date

May 5, 2026

Last Update Submit

May 13, 2026

Conditions

Keywords

Transtibial prosthesisProsthetic socketFlexible socketAccess SocketComfortQuality of lifeRehabilitationcross over trialPatient Specific Scale

Outcome Measures

Primary Outcomes (1)

  • Patient Specific Functional Scale (PSFS) score

    Patient-centered self-report tool. The patient identifies 3-5 specific activities they have difficulty performing, then rates their ability on a 0-10 scale (0 = unable to perform, 10 = able to perform at pre-injury level). The final score is the mean of the ratings

    One time at the end of each 4-week wear period (V1, V2 and V3)

Secondary Outcomes (5)

  • Socket Comfort Scale (SCS) score

    One time at the end of each 4-week wear period (V1, V2 and V3)

  • Orthotics Prosthetics Users Survey (OPUS) score

    One time at the end of each 4-week wear period (V1, V2 and V3)

  • Trinity Amputation and Prosthesis Experience Scale - Revised (TAPES-R) score

    One time at the end of each 4-week wear period (V1, V2 and V3)

  • Prosthesis Evaluation Questionnaire - Utility subscale (PEQ-U) score

    One time at the end of each 4-week wear period (V1, V2 and V3)

  • Proportion of participants electing to keep the Access Socket at study completion

    Through study completion, an average of 10 weeks

Study Arms (2)

Group 1 (RS -> AS)

ACTIVE COMPARATOR

Participants wear their standard rigid socket (RS) for 4 weeks, complete evaluation, then switch to the Access Socket (AS) for 1-2 weeks of adaptation followed by 4 weeks of wear, with a second evaluation.

Device: Access Socket (AS)Device: Rigid Socket (RS)

Group 2 (AS -> RS)

ACTIVE COMPARATOR

Participants receive the Access Socket (AS) first, with 1-2 weeks of adaptation followed by 4 weeks of wear and evaluation. They then switch to the standard rigid socket (RS) for 1-2 weeks of adaptation and 4 weeks of wear, with a second evaluation.

Device: Access Socket (AS)Device: Rigid Socket (RS)

Interventions

Hybrid prosthetic socket combining a rigid carbon-fiber structure in load-bearing areas (lateral, postero-inferior, inferior) with flexible urethane-resin (ProtheFLEX®) zones in regions typically rigid in conventional sockets. Manufactured from the same plaster mold as the rigid socket to ensure identical internal geometry.

Group 1 (RS -> AS)Group 2 (AS -> RS)

Conventional definitive carbon-fiber rigid socket, currently the only socket type reimbursed in France for transtibial amputation (LPPR-listed). Standard of care comparator.

Group 1 (RS -> AS)Group 2 (AS -> RS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Unilateral or bilateral transtibial amputation
  • Currently fitted with a definitive carbon rigid socket
  • Any residual-limb shape
  • Any etiology
  • Able to understand simple instructions, read, write, and provide informed consent - or able to be accompanied by a trusted person in case of inability to read/write autonomously
  • Provided free written informed consent
  • Aged 18 years or older
  • Affiliated to a social security system

You may not qualify if:

  • Use of hydroalcoholic solution (HAS) for socket donning
  • Currently fitted with a provisional socket
  • Neurological pathology limiting capacity to participate in activities
  • Orthopedic pathology limiting capacity to participate in activities
  • Pregnant or breastfeeding women
  • Minors
  • Persons not under legal protection or unable to express consent
  • Persons under guardianship or curatorship
  • Persons under judicial protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Hôpital National d'Instruction des Armées (HNIA) Percy

Clamart, 92140, France

RECRUITING

Hôpital Filieris de Freyming-Merlebach

Freyming-Merlebach, 57804, France

RECRUITING

CHU Grenoble Alpes - Hôpital Sud

Grenoble, 38434, France

RECRUITING

Institut Régional de Médecine Physique et de Réadaptation (IRR) - Filière Locomoteur

Nancy, 54000, France

RECRUITING

Insititution Nationale des Invalides

Paris, 75007, France

RECRUITING

Study Officials

  • Isabelle Loiret, MD

    Institut Régional de Médecine Physique et de Réadaptation (IRR), Nancy, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Double-blinding not feasible: participants can perceive differences in socket rigidity and prosthesis weight
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Open-label, two-arm randomized crossover trial. Each participant wears both sockets sequentially in a randomized order. Each socket period includes a 1-2 week adaptation/adjustment phase followed by a 4-week wear period before evaluation.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2026

First Posted

May 18, 2026

Study Start

April 27, 2026

Primary Completion (Estimated)

April 27, 2027

Study Completion (Estimated)

October 30, 2027

Last Updated

May 18, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

: Individual participant data will not be shared. Aggregated study results will be published in scientific journals and a summary report will be transmitted to the CPP within 12 months of study completion

Locations